Voice outcomes in patients with advanced laryngeal and hypopharyngeal cancer treated with chemo-radiotherapy

• Published in: Acta otorhino-laryngologica italica 2022-06, Vol.42 (3), p.243-249
• Main Authors: Álvarez-Marcos, César, Vicente-Benito, Andrea, Gayol-Fernández, Águeda, Pedregal-Mallo, Daniel, Sirgo-Rodríguez, Paloma, Santamarina-Rabanal, Liliana, Llorente, José Luis, López, Fernando, Rodrigo, Juan Pablo
• Format: Article
• Language: English
• Subjects: Laryngology
• ISSN: 1827-675X; 0392-100X; 1827-675X
• DOI: 10.14639/0392-100X-N1992

ObjectivePatients with locally advanced laryngeal and hypopharyngeal cancer (LHC) are often treated with chemo-radiotherapy to avoid total laryngectomy, although voice problems may occur even if not markedly manifest. We sought to evaluate the impact of chemoradiation on voice and quality of life. MethodsWe studied 21 patients with locally advanced LHC with tumour control at least two years after chemo-radiotherapy. None manifested clinical symptoms related to the treatment and maintained an activity considered as within normal limits. All patients had a voice handicap index (VHI) of less than 15. Voice function was evaluated by perceptual vocal analysis (CAPE-V) and aerodynamic and acoustic study. Quality of life was assessed with the EORTC-H&N35 (voice items 46, 53 and 54). ResultsVoice changes were frequent, with alterations in all CAPE-V attributes, and predominantly type II and III spectrograms in acoustic analysis (78%). The EORTC-H&N35 scale showed a reduction in scores in 10-40% of items related to voice. ConclusionsSubclinical voice disorders are common after chemo-radiotherapy. Although patients consider vocal impairment to be very minor and to not interfere with their daily life, it may contribute to a reduced quality of life.